Evaluation of SINGLE PORT (SP) Robotic Technology in Colorectal Surgery
Part of paid clinical trials in Sacramento, California.
- Sponsor
- University of California, Davis
- Study ID
- NCT05321134
- Status
- Recruiting
Conditions
- Colo-rectal Cancer
- Colorectal Disorders
- Colostomy Stoma
- Rectal Prolapse
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Single port robotic colorectal surgical procedure — DEVICEAfter screening and counseling, study subjects who wish to participate will undergo the colorectal surgical procedure (determined based on routine standard clinical care) using the alternate Intuitive Da Vinci Single Port SP system rather than the currently used multiport system, (Intuitive Da Vinci Multiport Xi System). Using standardized case report forms, the investigators will track clinical parameters and describe the safety \& quality event rate for SP platform transabdominal and transanal colorectal operations.
Study Details
Currently a multiport robotic surgery platform (Intuitive Xi) is widely available and used for colorectal surgery indications. A Single port platform (Intuitive SP) is FDA approved for Head and Neck and Urology but has not been widely used in colorectal surgery. This study seeks to evaluate the safe and effective use of the SP platform for colorectal surgery indications.
Key Dates
- Start date
- Apr 28, 2022
- Status verified
- May 2026
- Primary completion
- Apr 30, 2028
- Completion
- Apr 30, 2028
Study Design
- Enrollment
- 25 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Single Port Robotic Surgery ArmStudy subjects will undergo the colorectal surgical procedure (determined based on routine standard clinical care) using the Intuitive Da Vinci Single Port SP system
Primary Outcome Measure
Assess safety & quality event rate for SP platform transabdominal and transanal colorectal operations [ Time Frame: 30 days ]
Central Contacts
- Ankit Sarin, MD9167034472
- Pallavi Vaidya, BPharm9167346609
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| UC Davis Medical Center | Sacramento | California | 95817 | Ankit Sarin, MD |
Find similar trials in Sacramento, CA
By research site
Related Studies
- Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer PatientsPHASE2 · Recruiting · Vyriad, Inc. · Phoenix, Arizona
- Early Detection of Advanced Adenomas and Colorectal CancerRecruiting · City of Hope Medical Center · Monrovia, California
- Shield Post-Approval Study ProtocolRecruiting · Guardant Health, Inc. · Chandler, Arizona
- Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid TumorsPHASE1/PHASE2 · Recruiting · MBrace Therapeutics · San Francisco, California